Literature DB >> 17468818

Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer.

Misuzu Nakamura1, Yoshihiro Kido, Yoshinori Hosoya, Masahiko Yano, Hideo Nagai, Morito Monden.   

Abstract

PURPOSE: Using an instrument we developed to assess postoperative dysfunction objectively (Surg Today 2005;35:535-42), we compared postoperative dysfunction after 2 - field versus 3 - field lymph node dissection retrospectively, in patents undergoing esophageal cancer surgery.
METHODS: Subjects were selected randomly from among patients who had undergone radical surgery for squamous cell carcinoma of the thoracic esophagus followed by reconstruction with a gastric tube and a cervical anastomosis. Patients rated 32 items related to postoperative dysfunction according to a 5-grade scale. Postoperative gastrointestinal dysfunction was evaluated on the basis of the total score and the scores for seven symptom categories: decreased physical activity, symptoms of reflux, dumping-like syndrome, nausea and vomiting, passage dysfunction, pain, and diarrhea or soft feces.
RESULTS: We studied 42 patients, 22 of whom underwent 2-field lymph node dissection and 20 of whom underwent 3-field dissection. The total gastrointestinal dysfunction score was significantly higher in the 3-field group than in the 2-field group (78.4 +/- 14.1 points vs 67.9 +/- 16.9 points, P = 0.038). When we analyzed the data according to the symptom categories, the 3-field group had higher scores for decreased physical activity, symptoms of reflux, dumping-like syndrome, nausea and vomiting, and passage dysfunction.
CONCLUSION: Three-field lymph node dissection was associated with greater postoperative gastrointestinal dysfunction than 2-field lymph node dissection. Thus, the preoperative identification of those patients with esophageal cancer who are most likely to benefit from concurrent cervical lymph node dissection is essential.

Entities:  

Mesh:

Year:  2007        PMID: 17468818     DOI: 10.1007/s00595-006-3413-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

Review 1.  Two-field dissection is enough for esophageal cancer.

Authors:  S Law; J Wong
Journal:  Dis Esophagus       Date:  2001       Impact factor: 3.429

2.  Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.

Authors:  Shuichi Hironaka; Atsushi Ohtsu; Narikazu Boku; Manabu Muto; Fumio Nagashima; Hiroki Saito; Shigeaki Yoshida; Mitsuyo Nishimura; Masatora Haruno; Satoshi Ishikura; Takashi Ogino; Seiichiro Yamamoto; Atsushi Ochiai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-10-01       Impact factor: 7.038

Review 3.  Quality of life after esophageal surgery.

Authors:  Hiran C Fernando; James D Luketich
Journal:  Thorac Surg Clin       Date:  2004-08       Impact factor: 1.750

4.  Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy.

Authors:  M Baba; T Aikou; S Natsugoe; C Kusano; M Shimada; S Nakano; T Fukumoto; H Yoshinaka
Journal:  Dis Esophagus       Date:  1998-01       Impact factor: 3.429

5.  Reliability and validity of a new scale to assess postoperative dysfunction after resection of upper gastrointestinal carcinoma.

Authors:  Misuzu Nakamura; Yoshihiro Kido; Masahiko Yano; Yoshinori Hosoya
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

6.  Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer.

Authors:  H Shiozaki; M Yano; T Tsujinaka; M Inoue; S Tamura; Y Doki; T Yasuda; Y Fujiwara; M Monden
Journal:  Dis Esophagus       Date:  2001       Impact factor: 3.429

7.  A prospective comparison of quality of life measures for patients with esophageal cancer.

Authors:  Jane M Blazeby; Vasia Kavadas; Craig W Vickery; Rosemary Greenwood; Richard G Berrisford; Derek Alderson
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

8.  Radical lymph node dissection for cancer of the thoracic esophagus.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

9.  Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer.

Authors:  Wentao Fang; Hoichi Kato; Yuji Tachimori; Hiroyasu Igaki; Hiroshi Sato; Hiroyuki Daiko
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

10.  Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus.

Authors:  M Baba; T Aikou; H Yoshinaka; S Natsugoe; T Fukumoto; H Shimazu; K Akazawa
Journal:  Ann Surg       Date:  1994-03       Impact factor: 12.969

View more
  12 in total

Review 1.  Quality of life: A critical outcome for all surgical treatments of gastric cancer.

Authors:  Michael D McCall; Peter J Graham; Oliver F Bathe
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  The impact of cervical lymph node dissection on acid and duodenogastroesophageal reflux after intrathoracic esophagogastrostomy following transthoracic esophagectomy.

Authors:  Soichiro Asai; Masahide Fukaya; Kazushi Miyata; Keita Itatsu; Ryoji Miyahara; Kazuhiro Furukawa; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2019-06-19       Impact factor: 2.549

3.  The Impact of the Location of Esophagogastrostomy on Acid and Duodenogastroesophageal Reflux After Transthoracic Esophagectomy with Gastric Tube Reconstruction and Intrathoracic Esophagogastrostomy.

Authors:  Hiroaki Usui; Masahide Fukaya; Keita Itatsu; Kazushi Miyata; Ryoji Miyahara; Kohei Funasaka; Masato Nagino
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

Review 4.  Three-field lymph node dissection in esophageal cancer surgery.

Authors:  Satoru Matsuda; Hiroya Takeuchi; Hirofumi Kawakubo; Yuko Kitagawa
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  Clinical value of lymph node dissection for stage T1b mid-thoracic esophageal squamous cell carcinoma.

Authors:  Xiaofeng Chen; Yujie Chen; Feng Wang; Shuoyan Liu; Peng Chen; Hao He
Journal:  J Gastrointest Oncol       Date:  2021-08

6.  D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery.

Authors:  Jian-Kun Hu; Kun Yang; Bo Zhang; Xin-Zu Chen; Zhi-Xin Chen; Jia-Ping Chen
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

Review 7.  [Esophageal squamous cell carcinoma: pre-operative combined radiochemotherapy from a surgical oncological viewpoint].

Authors:  B L D M Brücher
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

Review 8.  Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer.

Authors:  Marc Jacobs; Rhiannon C Macefield; Jane M Blazeby; Ida J Korfage; Mark I van Berge Henegouwen; Hanneke C J M de Haes; Ellen M Smets; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2012-10-20       Impact factor: 4.147

9.  Presence and persistence of nutrition-related symptoms during the first year following esophagectomy with gastric tube reconstruction in clinically disease-free patients.

Authors:  E B Haverkort; J M Binnekade; O R C Busch; M I van Berge Henegouwen; R J de Haan; D J Gouma
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

10.  Photon Versus Proton Beam Therapy for T1-3 Squamous Cell Carcinoma of the Thoracic Esophagus Without Lymph Node Metastasis.

Authors:  Yang-Gun Suh; Unurjargal Bayasgalan; Heung Tae Kim; Jong Mog Lee; Moon Soo Kim; Youngjoo Lee; Doo Yeul Lee; Sung Uk Lee; Tae Hyun Kim; Sung Ho Moon
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.